RAFAEL HOLDINGS, INC. Amortization of Debt Issuance Costs
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of Debt Issuance Costs of $375.00 thousand for the 9-month period ending 2022-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2022-04-30 was $125.00K.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2022-01-31 was $125.00K.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2021-10-31 was $125.00K.
- RAFAEL HOLDINGS, INC. amortization of debt issuance costs for fiscal 2021 was $28.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-04-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $250.00K derived: sum of 2 quarters · filed 2023-06-13 | $375.00K 10-Q · filed 2023-06-13 | |
| 2022-01-31 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $250.00K 10-Q · filed 2023-03-14 | ||
| 2021-10-31 | $125.00K 10-Q · filed 2022-12-13 | |||
| 2021-07-31 | $28.00K 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |